NL-OMON37676已完成不适用
Genomic based risk stratification in prostate cancer screening. - ERSPC 2012/DNA
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 15,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Men randomised to the screening arm of ERSPC Rotterdam
- •- Signed informed consent
排除标准
- 未提供
研究者
相似试验
招募中
不适用
Prostate Cancer Genetic Risk Evaluation and Screening StudyProstatic NeoplasmBRCA2 MutationBRCA1 MutationATM Gene MutationMMR MutationLynch SyndromeGenetic Predisposition to DiseaseProstate CancerNCT05129605Massachusetts General Hospital400
撤回
不适用
Identification of Risk Allels for Prostate CancerProstate CancerNCT00323388University of New Mexico
进行中（未招募）
不适用
Integrated Genomic Prostate Score With MRI Targeted Prostate BiopsiesProstate CancerNCT04541030National Cancer Institute (NCI)241
已完成
1 期
Prostate Cancer Genomic HeterogeneityPROSTATE CANCERNCT02022371University College London Hospitals50
已完成
不适用
Individual risk assessment for prostate cancer: an impact analysis.Prostate carcinoma1003858810036958prostate cancerNL-OMON35373Erasmus MC, Universitair Medisch Centrum Rotterdam650